The National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013
The National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulatio…
Typestatutory instrumentDate14 Feb 2013Articles364Versions held32Cited by57 documentsLast changed1 Oct 2026
- 3Pharmaceutical needs assessments
- 4Information to be contained in pharmaceutical needs assessments
- 5Date by which the first HWB pharmaceutical needs assessments are to be published
- 6Subsequent assessments and later first assessments
- 7Temporary extension of earlier pharmaceutical needs assessments and access by NHS England and HWBs to pharma
- 8Consultation on pharmaceutical needs assessments
- 9Matters for consideration when making assessments
- 10Pharmaceutical lists …
- 11Terms of service of NHS chemists: general
- 12Routine applications for inclusion in or amendments to a pharmaceutical list
- 13Current needs: additional matters to which NHS England must have regard
- 14Current needs: consequences of additional matters
- 15Future needs: additional matters to which NHS England must have regard
- 16Future needs: consequences of additional matters
- 17Improvements or better access to the current service: additional matters to which NHS England must have reg
- 18Unforeseen benefits applications: additional matters to which NHS England must have regard
- 19Applications to which regulation 17 or 18 applies: consequences of additional matters
- 20Future improvements or better access: additional matters to which NHS England must have regard
- 21Future improvements or better access: consequences of additional matters
- 21aPNA based applications for new premises offering additional or different opening hours
- 22Refusal of routine applications that are based on neither a pharmaceutical needs assessment nor unforeseen
- 23Applications from NHS chemists in respect of providing directed services
- 24Relocations that do not result in significant change to pharmaceutical services provision
- 25Distance selling premises applications
- 25aTransitional provision: distance selling premises applications for new inclusions made before 23rd June 20
- 26Change of ownership applications
- 26aConsolidation onto an existing site
- 27Applications for temporary listings arising out of suspensions
- 28Applications from persons exercising a right of return to a pharmaceutical list
- 29Temporary arrangements during emergencies or because of circumstances beyond the control of NHS chemists
- 36Determination that an area is a controlled locality
- 37Process for determining controlled localities: preliminary matters
- 38Process for determining controlled localities: local notification and deferment of routine applications
- 39Process of determining controlled localities: formulation of NHS England’s decision
- 40Applications for new pharmacy premises in controlled localities: refusals because of preliminary matters
- 41Applications for new pharmacy premises in controlled localities: reserved locations
- 42Second and subsequent determinations of reserved location status
- 43Determinations of reserved locations: supplemental matters
- 44Prejudice test in respect of routine applications for new pharmacy premises in a part of a controlled local
- 45Appeals against decisions under Part 7
- 46Dispensing doctor lists
- 47Terms of service of dispensing doctors: general
- 48Arrangements for the provision of pharmaceutical services by doctors: applications by patients
- 49Necessary services for temporary patients
- 50Discontinuation of arrangements for the provision of pharmaceutical services by doctors
- 51Outline consent and premises approval: applications by doctors
- 52Notification of applications for outline consent and premises approval
- 53Decisions on outline consent and premises approval applications and the taking effect of grants
- 54Premises approval: relocations of practice premises which are not significant before outline consent takes
- 55Premises approval: relocations of practice premises which are not significant after outline consent has tak
- 56Taking effect of premises approval where there is no related application for outline consent
- 57Gradual introduction of premises approval
- 58Temporary provision in cases of relocations or additional premises where premises approval has not taken ef
- 59Practice amalgamations
- 60Lapse of outline consent and premises approval
- 61Temporary arrangements during emergencies or circumstances beyond the control of a dispensing doctor
- 62Persons barred from taking part in decision making with regard to applications for outline consent or premi
- 63Appeals against decisions under Part 8
- 64Distance selling premises: specific conditions
- 65Core opening hours conditions
- 65aContinuity in respect of opening hours directions
- 66Conditions relating to providing directed services
- 66aConditions relating to independent prescribing
- 67Conditions relating to voluntary closure of premises
- 67aCondition relating to entering administration
- 68Conditions relating to local resolution of disputes over terms of service
- 69Local dispute resolution before serving remedial notices or breach notices
- 70Breaches of terms of service: remedial notices
- 71Breaches of terms of service: breach notices
- 71aIssuing breach or remedial notices while a disease is or in anticipation of a disease being imminently pan
- 72Payment withholdings: supplementary matters
- 73Removal of listings: cases relating to remedial notices and breach notices
- 74Removal of listings: cases relating to death, incapacity or cessation of service
- 75Voluntary and automatic removal of listings: change of ownership, relocation, temporary provision and volun
- 76Limitation on withdrawal from pharmaceutical lists while fitness investigations or proceedings are ongoing
- 77Appeals against decisions under Part 10
- 78Extended meaning of “health scheme” in fraud cases
- 79Review of decisions to impose fitness conditions originally imposed on grants of applications
- 80Removal for breach of fitness conditions imposed under regulation 35 or 79
- 81Mandatory removal in suitability cases
- 82Fitness cases: procedures for removal or contingent removal from pharmaceutical lists
- 83Procedure for suspensions in fitness cases
- 84Procedure for reviewing some suspensions and contingent removal conditions
- 85General power to revoke suspensions in appropriate circumstances
- 86Internal handling of fitness information by NHS England or an agent of NHS England
- 87Review periods for national disqualifications
- 88Wider notifications of fitness decisions
- 89The Drug Tariff and section 164: general provisions
- 90Data to be provided to assist Drug Tariff determinations
- 91Remuneration of NHS chemists: instruments of appointment of NHS England
- 91aZero or nominal product reimbursement for … vaccines and antivirals
- 92Dispensing doctor remuneration
- 93The taking effect of determinations
- 94Overpayments
- 95Free supply of drugs, appliances and containers where the drug or appliance is supplied under pharmaceutica
- 96Refunds of prescription charges
- 97Reward scheme
- 98Payments to suspended chemists
- 99Designation of areas, premises or descriptions of premises
- 100Review of designations
- 101Cancellation of designations
- 102Terms of service for LPS schemes: general
- 102aSuspension of terms of schemes or of enforcement of terms of schemes while a disease is or in anticipatio
- 103LPS schemes: health service body status
- 104Development of LPS schemes
- 105Persons permitted to be parties to LPS schemes: fitness criteria
- 106LPS proposals: fitness information to be supplied
- 107Notification of proposals
- 108Right of return to pharmaceutical lists: LPS contractors
- 109LPS pilot schemes: health service body status
- 110LPS pilot schemes: termination
- 111Emergencies requiring the flexible provision of local pharmaceutical services
- 112Sharing of information about LPS chemists and their employees with the General Pharmaceutical Council
- 113Directions to the First-tier Tribunal relating to local pharmaceutical services
- 114Lists of LPS chemists
- 115Notification by NHS England of changes to its lists
- 116Authorised persons to apply for services
- 117Functions of the Secretary of State to be exercised by the NHS Litigation Authority
- 118Proceedings relating to overridden arrangements
- 119Transitional provisions
- 119aTransitional provisions in respect of drugs or appliances supplied in accordance with SSPs
- 120Amendments and revocations
- 121Review of these Regulations
1 Information to be included in routine and excepted applications
- 1Information to be included in all routine and excepted applications
- 2Information to be included in all routine and excepted applications for inclusion in a pharmaceutical list
- 3Fitness information about individuals: routine and excepted applications for inclusion in a pharmaceutical l
- 4Fitness information about corporate bodies: routine and excepted applications for inclusion in a pharmaceuti
- 5Fitness information that has already been provided under pharmaceutical or local pharmaceutical services
- 5aUpdating of information about or relating to a superintendent
- 6Applications seeking the listing of premises that are already, or are in close proximity to, listed chemist
- 7Additional information to be included with routine applications
- 8Additional information to be included with excepted applications
- 9Undertakings
- 10Nature of details to be supplied
- 11Relevant information or documentation
- 12Failure to provide undertakings or fees
- 13Functions of NHS England in relation to fitness information relevant to applications: aggregation of inform
- 14Deferral of notifiable applications prior to notification
- 15Refusal of notifiable applications prior to notification because of the language requirement for some NHS p
- 16Refusal of notifiable applications on fitness grounds prior to notification
- 17Proposed new pharmacy premises in controlled localities: refusal of routine applications because of prelimi
3 Notification of certain applications
4 Determination and deferral of applications
- 22Flexibility with regard to determining or deferring applications
- 23Additional matters for consideration in relation to applications for inclusion in a pharmaceutical list
- 24Action following deferrals
- 25Oral hearings
- 26Persons barred from taking part in decision making on routine and excepted applications
- 27Timetable for determining applications
5 Notification, taking effect of decisions and rights of appeal to the Secretary of State
- 28Notification of decisions on routine and excepted applications
- 29Template notice of commencement to be included with a notice of decision
- 29aTemplate notice of consolidation
- 30Third party rights of appeal to the Secretary of State where an application is granted
- 31Conditional grant of applications where the address of the premises is unknown
- 32Changes to the premises specified in an application after its grant but before the listing of the premises
- 33Conditional grant in cases relating to future needs or future improvements or better access
- 34Taking effect of listing decisions: general
- 34aTaking effect of decisions relating to business consolidations
- 35Notice requiring the commencement of pharmaceutical services
- 36Appeals to the Secretary of State by the applicant
- 3Essential services
- 4Dispensing services
- 5Dispensing of drugs and appliances
- 5aSupply in accordance with a SSP
- 5bSupply in accordance with a PTP or a PTPGD
- 5cSupply in accordance with a LPIV
- 6Urgent supply without a prescription
- 7Preliminary matters before providing ordered drugs or appliances
- 7aSub-contracting aspects of dispensing under “hub and spoke” arrangements
- 7bObjection to and discontinuation of hub and spoke arrangements
- 7cHub and spoke arrangements: sharing of “relevant data” between different businesses
- 8Providing ordered drugs or appliances
- 9Refusal to provide drugs or appliances ordered
- 10Further activities to be carried out in connection with the provision of dispensing services
- 11Additional requirements in relation to electronic prescribing
- 12Additional requirements in relation to specified appliances
- 13Disposal service in respect of unwanted drugs
- 14Basic procedure in respect of unwanted drugs
- 15Further activities to be carried out in connection with the disposal of unwanted drugs
- 16Promotion of healthy lifestyles
- 17Prescription linked intervention
- 18… Health campaigns
- 19Signposting
- 20Service outline in respect of signposting
- 21Support for self-care
- 22Service outline in respect of support for self-care
- 22aHome delivery service while a disease is or in anticipation of a disease being imminently pandemic etc.
- 22aaHome delivery of notified items while a disease is or in anticipation of a disease being imminently pande
- 22bDischarge medicines service
- 22cService outline in respect of the discharge medicines service
- 23Pharmacy opening hours: general
- 23aLocal hours plans
- 23bClosure for learning and development
- 24Matters to be considered when issuing directions in respect of pharmacy premises core opening hours
- 25Determination of pharmacy premises core opening hours instigated by NHS England
- 26Determination of pharmacy premises core opening hours instigated by the NHS pharmacist
- 27Temporary opening hours and closures during an emergency requiring the flexible provision of pharmaceutical
- 27aPharmacy opening hours: arrangements while a disease is or in anticipation of a disease being imminently p
- 27bFlexible provision of relevant immunisation services during a pandemic etc.
- 28Clinical governance and the promotion of healthy living
- 28aPremises requirements in respect of consultation rooms
- 28bConsultations held from distance selling premises and some small pharmacy premises
- 28cDistance selling premises requirements in respect of websites and health promotion zones
- 29Professional Standards
- 29aAccessing summary care records
- 29bElectronic Prescription Service access
- 29cContact via NHS.net Connect, pharmacy profiles and the Central Alerting System
- 29dBusiness continuity plans to deal with temporary suspensions
- 30Inducements etc.
- 31Duty to provide information about fitness matters as they arise
- 32Other information to be supplied
- 32aFacilitating remote access to pharmaceutical services
- 33Co-operation with NHS England
- 34Complaints
- 35Inspections and access to information
- 1Division of responsibilities between individuals and corporate bodies
- 2Breaches by directors
- 3Dispensing services
- 4Dispensing of appliances
- 4aSupply in accordance with a SSP
- 5Urgent supply without a prescription
- 6Preliminary matters before providing appliances
- 7Providing appliances
- 8Refusal to provide appliances ordered
- 9Further activities to be carried out in connection with the provision of dispensing services
- 10Additional requirements in relation to electronic prescribing
- 11Additional requirements in relation to specified appliances
- 12Signposting
- 13Opening hours: general
- 14Matters to be considered when issuing directions in respect of core opening hours
- 15Determination of core opening hours instigated by NHS England
- 16Determination of core opening hours instigated by the NHS appliance contractor
- 17Temporary open hours and closures during an emergency requiring the flexible provision of pharmaceutical se
- 18Clinical governance
- 19Professional Standards
- 20Inducements etc.
- 21Duty to provide information about fitness matters as they arise
- 22Other information to be supplied
- 23Co-operation with NHS England
- 24Complaints
- 25Inspections and access to information
- 1Persons duly authorised to dispense on behalf of dispensing doctors
- 2Dispensing of drugs and appliances ordered by another prescriber
- 3Dispensing of drugs and appliances ordered by the dispensing doctor
- 3aSupply in accordance with a SSP
- 3bSupply in accordance with a PTP or a PTPGD
- 3cSupply in accordance with a LPIV
- 4Preliminary matters before providing ordered drugs or appliances
- 4zaSub-contracting aspects of dispensing under “hub and spoke” arrangements
- 4zbObjection to and termination of hub and spoke arrangements
- 4zcHub and spoke arrangements: sharing of “relevant data” between different businesses
- 4aCharge exemption and remission of charges: declarations and checks
- 4bChecks and records in the case of supply in accordance with a SSP
- 5Provision of Scheduled drugs
- 6Refusal to provide drugs or appliances ordered
- 7Dispensing doctors issuing prescription forms which may be presented to an NHS chemist
- 7aHome delivery service while a disease is or in anticipation of a disease being imminently pandemic etc.
- 7aaHome delivery of notified items while a disease is or in anticipation of a disease being imminently pandem
- 8Complaints procedures
- 9Inspections and access to information
- 10Voluntary closure of premises
- 1General provisions
- 2Restrictions in an LPS scheme on supply
- 3Dispensing
- 3aSupply in accordance with a SSP
- 3bSupply in accordance with a LPIV
- 4Urgent supply without a prescription
- 5Preliminary matters before providing ordered drugs or appliances
- 5aSub-contracting aspects of dispensing under “hub and spoke” arrangements
- 5bObjection to and discontinuation of hub and spoke arrangements
- 5cHub and spoke arrangements: sharing of “relevant data” between different businesses
- 6Providing ordered drugs or appliances
- 7Refusal to provide drugs or appliances ordered
- 8Further activities to be carried out in connection with the provision of dispensing services
- 9Additional requirements in relation to electronic prescribing
- 10Further activities in connection with repeat dispensing
- 10aHome delivery service while a disease is or in anticipation of a disease being imminently pandemic etc.
- 10aaHome delivery of notified items while a disease is or in anticipation of a disease being imminently pande
- 11Information to be provided for NHS England’s lists
- 12Clinical governance
- 13Professional Standards
- 13aAccessing summary care records
- 13bElectronic Prescription Service access
- 13cContact via NHS.net Connect and the Central Alerting System
- 14Inducements etc
- 15Duty to provide information about fitness to practise matters as they arise
- 16Co-operation with NHS England
- 17Charges for drugs, appliances and containers, and ownership of containers
- 18Refunds of prescription charges
- 19Remuneration, overpayments etc
- 20Local resolution of disputes
- 21Dispute resolution: non-NHS contracts
- 22NHS dispute resolution procedure
- 23Determination of dispute
- 24Disputes: supplemental
- 25Complaints
- 26Variation of LPS schemes
- 27Termination by agreement
- 28Termination by serving notice
- 29Termination of arrangements by NHS England on grounds of suitability etc
- 30Termination by NHS England: patient safety and material financial loss
- 31Termination and the NHS dispute resolution procedure
- 32Third party rights
- 1The continuity principles
- 2Listing applications under the 2005 Regulations: NHS chemists
- 3Listing applications under the 2012 Regulations: NHS chemists
- 4Listing applications under the 2005 Regulations: dispensing doctors
- 5Listing applications under the 2012 Regulations: dispensing doctors
- 6Outstanding cases relating to dispensing contractor lists
- 7Controlled localities
- 8Reserved locations
- 9Gradual discontinuation of the provision of pharmaceutical services by doctors
- 10Gradual introduction of the provision of pharmaceutical services by doctors
- 11Giving effect to listing decisions: pharmaceutical lists and dispensing doctor lists
- 12Pharmaceutical lists, EPS lists and dispensing doctor lists: continuity of entries and decisions
- 13Service provision issues: NHS chemists
- 14Service provision issues: dispensing doctors
- 15LPS schemes: replacement of Primary Care Trusts with NHS England and service provision issues
- 16Notification of LPS designations and completion of reviews
- 17The application of Group 12 of Schedule 8 to the Value Added Tax Act 1994
- 1Amendment of the National Health Service (Charges for Drugs and Appliances) Regulations 2000
- 2Revocation of the National Health Service (Local Pharmaceutical Services and Pharmaceutical Services) Regula
- 3Revocation of the National Health Service (Local Pharmaceutical Services and Pharmaceutical Services) (No. 2
- 4Revocation of the National Health Service (Pharmaceutical Services) Amendment Regulations 2005
- 5Revocation of the National Health Service (Local Pharmaceutical Services etc.) Regulations 2006 and amendmen
- 6Revocation of the National Health Service (Pharmaceutical Services) (Amendment) Regulations 2006
- 7Amendments to the Local Authority Social Services and National Health Service Complaints (England) Regulatio
- 8Revocation of the National Health Service (Pharmaceutical Services and Local Pharmaceutical Services) Amendm
- 9Revocation of the National Health Service (Pharmaceutical Services and Local Pharmaceutical Services) (Amend
- 10Revocation of the National Health Service (Local Pharmaceutical Services) Amendment Regulations 2012
- 11Revocation of the National Health Service (Pharmaceutical Services) Regulations 2012 and of amendments to t
- 12Amendment of the Local Authorities (Partnership Arrangements, Care Trusts, Public Health and Local Healthwa
Source: legislation.gov.uk (The National Archives), UK legislation with its point-in-time versions. Official publication. Reuse: Open Government Licence v3.0.